Clinical trial

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced…

NCT00264056 · Fachklinik Hornheide an der Universität Münster, Other · Unknown status

Key facts

NCT number NCT00264056
Title Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
Official title Evaluation of the Safety and Efficacy of Systemic Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Locally Inoperable Progressive Soft Tissue Metastases
Lead sponsor Fachklinik Hornheide an der Universität Münster, Other
Status Unknown status
Study type Interventional
Conditions Advanced Metastastic Malignant Melanoma, Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Intervention type Device
Interventions hyperthermia
Enrollment 26
Start date Dec 1, 2005
Completion Jun 1, 2007
First posted Dec 12, 2005
Last update posted Dec 12, 2005
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies